INmune Bio, Inc. (INMB) Tops Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts INMB Hot Sheet
Join SI Premium – FREE
INmune Bio, Inc. (NASDAQ: INMB) reported Q1 EPS of ($0.43), $0.06 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $50 thousand.
For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl Credit Income Corp caps Q2 tender offer at 5% of shares
- Jabil files mixed shelf offering with SEC, size undisclosed
- Fed Daly: AI investment sparks inflation fears, Fed walks tightrope
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
